Breakthrough in diabetes care - The Daily Star
Overview
Diabetes is one of the four major types of noncomunicable diseases (NCDs) that make the largest contribution to morbidity and mortality worldwide. The prevalence of diabetes increasing in Bangladesh. In 2021, the International Diabetes Federation estimated 13.1 milion people were living with diabetes in Bangladesh and projected to be almost doubled by 2025.While managing diabetes, one of the prime concerns of healthcare professionals remains as how to reduce HbA1c eficiently without trigering any other comorbidities.
Key Information
SGLT2 (Sodium-glucose Cotransporter-2) Inhibitors, in that context, plays a pivotal role in the diabetes treatment regime. Synovia Pharma brought a breakthrough new and inovative solutions to cater to the unmet neds of Bangladeshi patients, says a pres release.Eminent physician Profesor A K Azad Khan, National Profesor and President of the Diabetes Asociation of Bangladesh graced the launching event as the Chief Guest.
Summary
Profesor Md Faruque Pathan, Profesor of Endocrinology, BIRDEM General Hospital chaired the programe where Profesor S M Ashrafuzaman - Profesor and President of Bangladesh Endocrine Society was present as the Special Guest.Prof Indrajit Prasad, Head of Endocrinology, Dhaka Medical Colege Hospital presented 'Diabetes Management Focusing on CVD Outcome' and Prof Shamim Ahmed, National Institute of Kidney Diseases & Urology (NIKDU) presented 'Diabetes Management Focusing on Renal Protection.'রাজশাহীর ৯ ভোটকেন্দ্রের ১৮ বুথে জেলা পরিষদ নির্বাচন চলছে।source
Frequently Asked Questions
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
Share this article